Clinical trial
Pharmacological Modulation of Hippocampal Activity in Psychosis 2
NCT04559529 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacological Modulation of Hippocampal Activity in Psychosis 2
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 23, 2020
- Completion date
- December 31, 2023
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia; psychosis